• Have any questions?
  • +1-888-INTL-SOS
  • support@globalreachhealth.com
  • Home
  • About
    • About
    • Licensure and Compliance
    • Company Brochure
    • Leadership
    • Careers
  • Divisions
    • Global Reach Rx
      • Service Countries
      • Pharmacy Discount Card
    • Global Reach Rx USA
    • Global Reach Arabia
    • Global Reach Pharma
    • Global Reach Financial Services
    • Global Reach Technology Services
    • Global Reach Miracle Foundation
    • Global Reach Health Clinic
    • Now Salud
  • Member Savings Programs
    • Wellevate Store
    • Pharmacy Discount Card
    • American Vaccine
    • Global immunization
  • News
  • Contact
  • Accessibility
  • Cookie Policy
  • Contact Us
  • Legal Disclaimer
  • Privacy Policy
  • Security
  • Sitemap
✕

News

  • Home
  • News
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Global Reach Health News
  • Pharmaceutical News
  • Uncategorized
  • All
  • Global healthcare
  • Global Reach Health
  • Health
  • Insurance
  • International Health Insurance
  • International Medical Assistance
  • International Medical Insurance
  • pharmace
  • Pharmaceutical
  • Pharmaceutical News
  • Pharmacy Benefits Management
  • Technology
  • All
  • GlobalReach Health
October 18, 2021

Cyltezo Will Be Interchangeable with Humira at the Pharmacy

October 18, 2021

Bryant Ranch Prepack Recalls Mislabeled Muscle Relaxant

October 18, 2021 – Bryant Ranch Prepack has issued a recall for one lot of Methocarbamol 500mg Tablets, as the bottles are mislabeled and instead contain Methocarbamol 750mg
October 15, 2021

Flucelvax Quadrivalent Approved for Broader Age Group

October 15, 2021 – The U.S. FDA has expanded the indication for Flucelvax® Quadrivalent (influenza vaccine) to prevent the flu (caused by influenza virus subtypes A and B)
October 15, 2021

Tecentriq Granted New Indication for Non-Small Cell Lung Cancer

October 15, 2021 – The U.S. FDA has approved a new indication for Genentech’s Tecentriq® (atezolizumab) for use as an adjuvant treatment following surgery
October 14, 2021

Lupin Pharmaceuticals Recalls All Irbesartan and Irbesartan/HCTZ

October 14, 2021 – Lupin Pharmaceuticals has recalled all batches of its Irbesartan Tablets USP 75mg, 150mg, and 300mg in the United States, as well as all batches
October 13, 2021

Verzenio Receives New Indication for High-Risk Early Breast Cancer

October 13, 2021 – Verzenio® (abemaciclib) is now approved as an adjuvant treatment for HR-positive, HER2-negative, node-positive early breast cancer in adults who are
October 12, 2021

Teligent Recalls Five Additional Lots of Lidocaine Topical Solution

October 12, 2021 – Teligent Pharma has recalled five lots of Lidocaine HCl Topical Solution 4%, 50mL, in a screw cap glass bottle. The affected lidocaine was found to be super
October 11, 2021

Dextenza Approved to Treat Itching in the Eye Caused by Allergies

October 11, 2021 – The U.S. FDA has approved a new indication for Ocular Therapeutix’s Dextenza® (dexamethasone ophthalmic insert) to treat ocular itching associated
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101
Next page

Search

✕

Global Healthcare News

Keep up-to-date with global healthcare news including pharma, medical assistance, international insurance and technology.

Latest posts

  • 0
    OTHER ANNOUNCEMENTS AND ARTICLES
    October 10, 2024
  • 0
    GENERIC DRUG APPROVALS
    September 30, 2024

Categories

  • Global Reach Health News
  • Pharmaceutical News
  • Uncategorized

Tags

Global healthcare Global Reach Health Health Insurance International Health Insurance International Medical Assistance International Medical Insurance pharmace Pharmaceutical Pharmaceutical News Pharmacy Benefits Management Technology

About Global Reach Health

Global Reach Health is a diverse group of global healthcare divisions and partners delivering healthcare solutions across the globe.

Global Reach Health administrates five separate divisions to deliver seamless cross border healthcare solutions and services for a myriad of clients around the globe including insurers, pharmacies, hospitals and clinics, assistance firms, cost containment companies, third party administrators plus public entities and private corporations.

Important Links

  • Accessibility
  • Cookie Policy
  • Contact Us
  • Legal Disclaimer
  • Privacy Policy
  • Security
  • Sitemap

Recent posts

  • 0
    OTHER ANNOUNCEMENTS AND ARTICLES
    October 10, 2024
  • 0
    GENERIC DRUG APPROVALS
    September 30, 2024


© 2019 - 2025 Global Reach Health. All Rights Reserved.
Contact